A critical literature review of health economic evaluations in pertussis booster vaccination

References

• Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? Clin. Infect. Dis.32(12), 1698–1699 (2001).
   PubMed Web of Science ®Google Scholar
• Black RE et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet375(9730), 1969–1987 (2010).
   PubMed Web of Science ®Google Scholar
• Floret D. Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units. Arch. Pediatr.8(Suppl. 4), S705–S711 (2001).
   Google Scholar
• Zepp F, Heininger U, Mertsola J et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect. Dis.11(7), 557–570 (2011).
   PubMed Web of Science ®Google Scholar
• Fonteneau L, Guthmann JP, Collet M, Vilain A, Herbet J, Lévy-Bruhl D. Vaccination coverage estimated based on data found in 24th month health certificates of infants, France, 2004–2007. Bull. Epidemiologique Hebdomadaire31–32, 329–333 (2010).
   Google Scholar
• De Greeff S, De Melker H, Mooi F. Pertussis in the Netherlands. Nederlands Tijdschrift Voor Geneeskunde154, A1383 (2010).
   Google Scholar
• Von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect. Dis.2(12), 744–750 (2002).
   PubMed Web of Science ®Google Scholar
• Skowronski DM, De Serres G, MacDonald D et al. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis.185(10), 1448–1453 (2002).
   PubMed Web of Science ®Google Scholar
• Guris D, Strebel PM, Bardenheier B et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults. Clin. Infect. Dis.28(6), 1230–1237 (1999).
   PubMed Web of Science ®Google Scholar
• Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine25(14), 2634–2642 (2007).
   PubMed Web of Science ®Google Scholar
• Pertussis vaccines: WHO position paper. Wkly Epidemiol. Rec.85(40), 385–400 (2010).
   PubMedGoogle Scholar
• CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on immunization practices, 2010. MMWR Morb. Mortal. Wkly Rep.60(1), 13–15 (2011).
   PubMedGoogle Scholar
• De Vries R, Kretzschmar M, Schellekens JFP et al. Cost–effectiveness of adolescent pertussis vaccination for The Netherlands: using an individual-based dynamic model. PLoS One5(10), 13392 (2010).
   PubMed Web of Science ®Google Scholar
• Caro JJ, Getsios D, El-Hadi W, Payne K, O’Brien J. Pertussis immunization of adolescents in the US: an economic evaluation. Paediatr. Infect. Dis. J.24(Suppl. 5), 75–82 (2005).
   PubMedGoogle Scholar
• Lee GM, LeBaron CW, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics115(6), 1675–1684 (2005).
   PubMed Web of Science ®Google Scholar
• Coudeville L, Van Rie A, Getsios D, Caro JJ, Crépey P, Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One4(7), e6284 (2009).
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Walker JH, Hemels ME. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine22(31–32), 4215–4227 (2004).
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Walker JH, De Serres G, Einarson TR. Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada. Paediatr. Drugs7(2), 123–136 (2005).
   PubMedGoogle Scholar
• Edmunds WJ, Brisson M, Melegaro A, Gay NJ. The potential cost–effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine20(9–10), 1316–1330 (2002).
   PubMed Web of Science ®Google Scholar
• Lee G, Riffelmannd M, Von Konig C. Cost–effectiveness of adult pertussis vaccination in Germany. Vaccine26(29–30), 3673–3679 (2008).
   PubMed Web of Science ®Google Scholar
• Westra TA, De Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost–effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin. Ther.32(8), 1479–1495 (2010).
   PubMed Web of Science ®Google Scholar
• Scuffham PA, McIntyre PB. Pertussis vaccination strategies for neonates – an exploratory cost–effectiveness analysis. Vaccine22(21–22), 2953–2964 (2004).
   PubMedGoogle Scholar
• Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost–benefit analysis. Clin. Infect. Dis.39(1), 20–28 (2004).
   PubMed Web of Science ®Google Scholar
• Hay JW, Ward JI. Economic considerations for pertussis booster vaccination in adolescents. Pediatr. Infect. Dis. J.24(Suppl. 6), 127–133 (2005).
   Google Scholar
• Lee GM, Murphy TV, Lett S et al. Cost effectiveness of pertussis vaccination in adults. Am. J. Prev. Med.32(3), 186–193 (2007).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Njamkepo E, Bourillon A et al. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J.26(4), 293–299 (2007).
   PubMed Web of Science ®Google Scholar
• Cherry JD. Epidemiology of pertussis. Pediatr. Infect. Dis. J.25(4), 361–362 (2006).
   PubMed Web of Science ®Google Scholar
• Lee GM, Salomon JA, LeBaron CW, Lieu TA. Health-state valuations for pertussis: methods for valuing short-term health states. Health Qual. Life Outcomes3, 17 (2005).
   PubMedGoogle Scholar
• Murray CJ. Rethinking DALYs. In: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Murray CJ, Lopez AD (Eds). Harvard School of Public Health, MA, USA (1996).
   Google Scholar
• The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Murray CJ, Lopez AD (Eds). Harvard School of Public Health, MA, USA (1996).
   Google Scholar
• Stouthard M, Essink-Bot M, Bonsel G, Barendregt J, Kramers P. Disability Weights for Diseases in The Netherlands. Department of Public Health, Erasmus University, Rotterdam, The Netherlands (1997).
   Google Scholar
• Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl Acad. Sci. USA108(17), 7259–7264 (2011).
   PubMed Web of Science ®Google Scholar
• Plotkin S. The global pertussis initiative: process overview. Pediatr. Infect. Dis. J.24(5), 7–9 (2005).
   PubMedGoogle Scholar
• Johannesson M, Weinstein MC. On the decision rules of cost–effectiveness analysis. J. Health. Econ.12(4), 459–467 (1993).
   PubMed Web of Science ®Google Scholar
• Karlsson G, Johannesson M. The decision rules of cost–effectiveness analysis. Pharmacoeconomics9(2), 113–120 (1996).
   PubMed Web of Science ®Google Scholar
• Bala MV, Zarkin GA. Application of cost–effectiveness analysis to multiple products: a practical guide. Am. J. Manag. Care8(3), 211–218 (2002).
   PubMedGoogle Scholar
• Jit M, Brisson M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics29(5), 371–386 (2011).
   PubMed Web of Science ®Google Scholar
• Roiz J, Brisson M. Cost–effectiveness of pertussis adolescent booster in the netherlands: a dynamic model based analysis. Presented at: 29th Annual Meeting of the European Society for Pediatric Infectious Diseases. The Hague, The Netherlands, 7–11 June 2011.
   Google Scholar
• Weinstein MC, O’Brien B, Hornberger J et al. ISPOR task force on good research practices – modeling studies. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices – modeling studies. Value Health6(1), 9–17 (2003).
   PubMed Web of Science ®Google Scholar